RheumNow Podcast – Scleroderma and the Lung (3.1.19) Save

Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

1. The new Shingrix, (nonlive) recombinant zoster vaccine (RZV) is shown to be highly cost effective, even if only one dose is given. https://t.co/gXAd1sY70K 
2. Population cross sectional study from Israel analyzed 11,782 RA pts and 57,973 controls. Thyroid disease was increased in RA patients vs controls (16.0% v 11.7%, p < 0.001 HypoT4; OR = 1.42, 95% CI 1.34–1.50) and hyperthyroidism (OR = 1.26). https://t.co/f3UAeLOBGb   
3. Key features in distinguishing Adult onset Stills disease from Fever of unknown origin: Arthralgia, rash, sore throat, neutrophilia, ferritin >5xULN, LDH based on comparison study of 69 AOSD & 87 FUO pts. 3 or more fever peaks daily makes AOSD less likely. https://t.co/49X4GGludn 
4. Skin Findings of Dermatomyositis - a few here you may not know about including Holster sign, Psoriasiform changes in scalp, Gottrons sign & papules, heliotrope, Vneck shawl, periungual erythema, facial erythema, erythroderma, calcinosis. https://t.co/IKGSCQ04L1   
5. Metanalysis of 18 studies shows individuals with mult-site pain have a higher future risk for FALLS (OR = 1.74 (95%CI 1.57–1.93)). For high-quality studies, multisite pain pts have double the odds of a future falls. https://t.co/lZLl8z7SMk 
6. Nurses Health Study had 1528 incident #RA cases. Current smoking increased risk of seropositive (not Seronegative) RA (HR 1.47). Smoking cessation >10, >20, >30 yrs ago assoc w/ decreasing risk of seropos. RA, but risk still remains > 30 yrs (HR 1.30) https://t.co/1CsIcXtJ1I
7. Prospective cohort study of 93 Systemic sclerosis patients with ILD; 2/3 had diffuse SSc. Half had PH diagnosis w/in 7 yrs of SSc onset, 83% Rx with ILD therapy, 83% Rx for PH. Survival rate for SSc-ILD and PH at 3 years after PH diagnosis was 91%. https://t.co/ZmOmWutwxq   
8. 8.9% of systemic sclerosis pts were ANCA+, denoting a subset with increased risk of ILD (44.8% vs 21.8%, p < 0.001) and pulmonary embolism (8.6% vs 3.0%) in SSc. ANCA should be tested in SSc, as it identifies individuals with worse prognosis https://t.co/WhlEpxFdIG  
9. Among 548 pts referred to academic pain center & treated for back pain, 42% met fibromyalgia criteria. FM+ pts were more likely to be younger, unemployed, w/ greater pain severity, more neuropathic pain, depression, anxiety & lower physical function https://t.co/gse5CDnJ13 
10. Taiwanese insurance claims data study shows that Sjogrens syndrome patients (n=13398) have increased risk of osteonecrosis of jaw compared to 54K controls (0.08% vs 0.03%, p=0.017) & also bisphosphonate ONJ (adjusted HR=7.9, p<0.001). https://t.co/qQSV16muNN 
11. The Johns Hopkins Myositis Center is proud to announce the launch of the Peter Frampton Myositis Research Fund. https://t.co/SAVf1AEdqO Join @peterframpton and our Myositis Center team as we work to improve the lives of those impacted by #myositis https://t.co/BjOOaHYuJq
12. Early TNF inhibition in Early Psoriatic Arthritis    
13. FDA Slaps a Boxed Warning on Febuxostat for CV Risk 
14. Register to view RheumNow.Live online